Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 70.7 | 56.9 | 60.0 |
| Revenue growth | 24.2% | -5.2% | |
| Cost of goods sold | 20.1 | 13.4 | 12.6 |
| Gross profit | 50.6 | 43.5 | 47.5 |
| Gross margin | 71.6% | 76.4% | 79.0% |
| Sales and marketing | 14.2 | 13.7 | 17.6 |
| Research and development | 46.9 | 44.7 | 52.7 |
| General and administrative | 16.6 | 7.9 | 5.1 |
| EBIT | -27.1 | -22.8 | -28.0 |
| EBIT margin | -38.3% | -40.0% | -46.6% |
| Pre-tax income | -26.1 | -19.5 | -25.5 |
| Income taxes | 0.4 | 0.2 | 0.4 |
| Net income | -26.5 | -19.6 | -25.9 |
| Net margin | -37.5% | -34.5% | -43.2% |
| |
| Diluted EPS | ($0.80) | ($1.88) | ($2.72) |
| Shares outstanding (diluted) | 33.0 | 10.4 | 9.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|